This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Readings
Fong KM, Sekido Y, Minna JD. Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg 1999;118:1136–1152.
Gazdar AF, Minna JD. Targeted therapies for killing tumor cells. Proc Natl Acad Sci U S A 2001;98:10028–10030.
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57–70.
Hirsch FR, Franklin WA, Gazdar AF, et al. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001;7:5–22.
Hittelman WN. Genetic instability assessments in the lung cancerization field. In: Brambilla C, Brambilla E, eds. Lung Tumors: Fundamental Biology and Clinical Management. New York, NY: Marcel Dekker; 1999:255–267.
Hittelman WN. Molecular cytogenetic evidence for multistep tumorigenesis: implications for risk assessment and early detection. In: Srivastava S, Hensen DE, Gazdar A, eds. Molecular Pathology of Early Cancer. Washington, DC: IOS Press; 1999:385–404.
Hong WK, Spitz MR, Lippman SM. Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. J Clin Oncol 2000;18(21 suppl):9S–18S.
Khuri FR, Kurie JM. Antisense approaches enter the clinic. Clin Cancer Res 2000;6:1607–1610.
Kim ES, Hong WK, Khuri FR. Prevention of lung cancer. The new millennium. Chest Surg Clin N Am 2000;10:663–690.
Kurie JM. The biological basis for the use of retinoids in cancer prevention and treatment. Curr Opin Oncol 1999;11:497–502.
Kurie JM, Lippman SM, Hong WK. Chemoprevention trials: epithelial carcinogenesis and the biological basis of intervention. In: Bertino JR, ed. Encyclopedia of Cancer. Vol 1. San Diego, Calif: Academic Press; 1996;341–354.
Lippman SM, Spitz MR. Lung cancer chemoprevention: an integrated approach. J Clin Oncol 2001;19(18 suppl):74S–82S.
Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857–862.
Saccomano G, Archer VE, Auerbach O, et al. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974;33:256–270.
Spitz MR, Wei Q, Li G, et al. Genetic susceptibility to tobacco carcinogenesis. Cancer Invest 1999;17:645–659.
Swisher SG, Roth JA. Gene therapy in lung cancer. Curr Oncol Rep 2000;2:64–70.
Swisher SG, Roth JA, Komaki R, et al. A phase II trial of adenoviral mediated p53 gene transfer (RPR/INGN 201) in conjunction with radiation therapy in patients with localized non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2000;19:461.
Swisher SG, Roth JA, Nemunaitis J, et al. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 1999;91:763–771.
Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997;3(12 Pt 1):2237–2246.
Tong L, Spitz MR, Fueger JJ, et al. Lung carcinoma in former smokers. Cancer 1996;78:1004–1010.
Wistuba II, Gazdar AF, Minna JD. Molecular genetics of small cell lung carcinoma. Semin Oncol 2001;28(2 suppl 4):3–13.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Hittelman, W.N., Kurie, J.M., Swisher, S.G. (2003). Molecular Events in Lung Cancer and Implications for Prevention and Therapy. In: Fossella, F.V., Komaki, R., Putnam, J.B. (eds) Lung Cancer. M.D. Anderson Cancer Care Series. Springer, New York, NY. https://doi.org/10.1007/0-387-22652-4_15
Download citation
DOI: https://doi.org/10.1007/0-387-22652-4_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95507-0
Online ISBN: 978-0-387-22652-1
eBook Packages: Springer Book Archive